TriSalus Announces Positive Real-World Outcomes Of TriNav; Stock Drops In Pre-Market
TriSalus Life Sciences, Inc. (TLSI), Thursday announced the real-world safety and clinical outcomes data, published in Current Medical Research and Opinion, for TriNav device for the treatment of patients with hepatocellular carcinoma or HCC and liver metastases.
Source: rttnews.com